Thalamic involvement in fluctuating cognition in dementia with lewy bodies: Magnetic resonance evidences

Cerebral Cortex

Volumn 25, Issue 10, 2015, Pages 3682-3689

  Delli Pizzi, Stefano ^a,b   Franciotti, Raffaella ^a,b   Taylor, John Paul ^c   Thomas, Astrid ^a,b   Tartaro, Armando ^a   Onofrj, Marco ^a,b   Bonanni, Laura ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b Aging Research Center   (Italy)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Attention; Choline; Dementia with Lewy bodies; Fluctuating cognition; Thalamus

Indexed keywords

CHOLINE; CLONAZEPAM; CLOZAPINE; CREATINE; DONEPEZIL; LEVODOPA; N ACETYLASPARTIC ACID; NEUROTRANSMITTER; QUETIAPINE; RISPERIDONE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN REGION; CHOLINERGIC ACTIVITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; FEMALE; HUMAN; IN VIVO STUDY; MALE; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETO-OCCIPITAL SULCUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSORIMOTOR CORTEX; TEMPORAL CORTEX; THALAMUS; DIFFUSION WEIGHTED IMAGING; METABOLISM; NERVE TRACT; PATHOLOGY; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; COGNITION; DIFFUSION MAGNETIC RESONANCE IMAGING; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; NEURAL PATHWAYS; PROTON MAGNETIC RESONANCE SPECTROSCOPY; THALAMUS;

EID: 84948656240     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu220     Document Type: Article

References (78)

1. Aggleton JP, Brown MW. 1999. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci. 22:425-489.
2. Arend I, Rafal R, Ward R. 2008. Spatial and temporal deficits are regionally dissociable in patients with pulvinar lesions. Brain. 131:2140-2152.
3. Ballard C, O'Brien J, Gray A, Cormack F, Ayre G, Rowan E, Thompson P, Bucks R, McKeith I, Walker M et al. 2001. Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 58:977-982.
4. Ballard C, Walker M, O'Brien J, Rowan E, McKeith I. 2001. The characterisation and impact of 'fluctuating' cognition in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatr Psychiatry. 16:494-498.
5. Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, Barker GJ, Sillery EL, Sheehan K, Ciccar-elli O et al. 2003. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci. 6:750-757.
6. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. 2008. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up. Brain. 131:690-705.
7. Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. 2006. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Mov Disord. 21:1899-1907.
8. Canu E, McLaren DG, Fitzgerald ME, Bendlin BB, Zoccatelli G, Alessan-drini F, Pizzini FB, Ricciardi GK, Beltramello A, Johnson SC et al. 2010. Micro-structural diffusion changes are independent of macro-structural volume loss in moderate to severe Alzheimer's disease. J Alzheimers Dis. 19:963-976.
9. Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolko-witz OM, Jagust WJ, Chui HC, Miller BL et al. 2005. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but non-demented patients. Neurology. 64:282-289.
10. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HB. 1993. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging. 11:107-118.
11. Colloby SJ, Taylor JP, Davison CM, Lloyd JJ, Firbank MJ, McKeith IG, O'Brien JT. 2013. Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis. J Cereb Blood Flow Metab. 33:612-618.
12. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. 1994. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 44: 2308-2314.
13. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. 2004. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res. 1012:60-65.
14. Delli Pizzi S, Madonna R, Caulo M, Romani GL, De Caterina R, Tartaro A. 2012. MR angiography, MR imaging and proton MR spectroscopy in-vivo assessment of skeletal muscle ischemia in diabetic rats. PLoS One. 7:e44752.
15. Delli Pizzi S, Rossi C, Di Matteo V, Esposito E, Guarnieri S, Mariggiò MA, Franciotti R, Caulo M, Thomas A, Onofrj M et al. 2013. Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study. PLoS One. 8:e56501.
16. Delli Pizzi S, Rossi C, Di Matteo V, Esposito E, Guarnieri S, Mariggiò MA, Franciotti R, Caulo M, Thomas A, Onofrj M et al. 2014. Structural Alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study. PLoS ONE. 9:e86624.
17. Di Paola M, Macaluso E, Carlesimo GA, Tomaiuolo F, Worsley KJ, Fadda L, Caltagirone C. 2007. Episodic memory impairment in patients with Alzheimer's disease is correlated with entorhinal cortex atrophy. A voxel-based morphometry study. J Neurol. 254:774-781.
18. Dubois B, Slachevsky A, Litvan I, Pillon B. 2000. The FAB: a frontal assessment battery at bedside. Neurology. 55:1621-1626.
19. Fahn S, Elton RL. 1987. Members of the Unified Parkinson's Disease Rating Scale Development Committee. Unified Parkinson's disease rating scale. In: Fahn S et al. editors. Recent development in Parkinson's disease. Florham Park (NJ): Macmillan Healthcare Information. p. 153-164.
20. Fischer J, Whitney D. 2012. Attention gates visual coding in the human pulvinar. Nat Commun. 3:1051.
21. Fiset P, Paus T, Daloze T, Plourde G, Meuret P, Bonhomme V, Hajj-Ali N, Backman S, Evans A. 1999. Brain mechanisms of propofol-induced loss of consciousness in humans: a positron emission tomographic study. J Neurosci. 19:5506-5513.
22. Foucher JR, Otzenberger H, Gounot D. 2004. Where arousal meets attention: a simultaneous fMRI and EEG recording study. Neuro-image. 22:688-697.
23. Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M. 2013. Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison. Neurobiol Aging. 34:1148-1158.
24. Franciotti R, Iacono D, Della Penna S, Pizzella V, Torquati K, Onofrj M, Romani GL. 2006. Cortical rhythms reactivity in AD, LBD and normal subjects: a quantitative MEG study. Neurobiol Aging. 27:1100-1109.
25. Graff-Radford J, Boeve BF, Murray ME, Ferman TJ, Tosakulwong N, Lesnick TG, Maroney-Smith M, Senjem ML, Gunter J, Smith GE et al. 2014. Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies. Neurobiol Aging. 35:1483-1490.
26. Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G, Koretski J, Guidone E, Jiang L, Petrakis IL et al. 2012. Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biol Psychiatry. 71:239-246.
27. Hirata A, Castro-Alamancos MA. 2010. Neocortex network activation and deactivation states controlled by the thalamus. J Neurophysiol. 103:1147-1157.
28. Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E. 1999. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). NeuroReport. 10:1903-1907.
29. Johansen-Berg H, Behrens TE, Sillery E, Ciccarelli O, Thompson AJ, Smith SM, Matthews PM. 2005. Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cereb Cortex. 15:31-39.
30. Jurica PJ, Leitten CL, Mattis S, editors. 2001. DRS-2 Dementia rating scale 2. Psychological Assessment Resources Eds. Odessa: FI.
31. Kantarci K. 2013. Proton MRS in mild cognitive impairment. J Magn Reson Imaging. 37:770-777.
32. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ Jr et al. 2004. 1H MR spectroscopy in common dementias. Neurology. 63:1393-1398.
33. Karczewska-Kupczewska M, Tarasów E, Nikolajuk A, Stefanowicz M, Matulewicz N, Otziomek E, Górska M, Straczkowski M, Kowalska I. 2013. The effect of insulin infusion on the metabolites in cerebral tissues assessed with proton magnetic resonance spectroscopy in young healthy subjects with high and low insulin sensitivity. Diab Care. 36:2787-2793.
34. Kemp PM, Hoffmann SA, Tossici-Bolt L, Fleming JS, Holmes C. 2007. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun. 28:451-456.
35. Kenny ER, O'Brien JT, Firbank MJ, Blamire AM. 2013. Subcortical connectivity in dementia with Lewy bodies and Alzheimer's disease. Br J Psychiatry. 203:209-214.
36. Klein J. 2000. Membrane breakdown in acute and chronic neurodegen-eration: focus on choline-containing phospholipids. J Neural Transm. 107:1027-1063.
37. Klinkenberg I, Sambeth A, Blokland A. 2011. Acetylcholine and attention. Behav Brain Res. 221:430-442.
38. Kotagal V, Müller ML, Kaufer DI, Koeppe RA, Bohnen NI. 2012. Thal-amic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett. 514:169-172.
39. Lee DR, McKeith I, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, Thomas AJ. 2013. The Dementia Cognitive Fluctuation Scale, a New Psychometric Test for Clinicians to Identify Cognitive Fluctuations in People with Dementia. Am J Geriatr Psychiatry. 22:926-935.
40. Lee DR, Taylor JP, Thomas AJ. 2012. Assessment of cognitive fluctuation in dementia: a systematic review of the literature. Int J Geriatr Psychiatry. 27:989-998.
41. Llinás RR, Steriade M. 2006. Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 95:3297-3308.
42. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT. 2001. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 56: 643-649.
43. MacKay S, Ezekiel F, Di Sclafani V, Meyerhoff DJ, Gerson J, Norman D, Fein G, Weiner MW. 1996. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology. 198:537-545.
44. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. 2000. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 356:2031-2036.
45. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK et al. Consortium on DLB. 2005. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65:1863-1872.
46. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:939-944.
47. Molina JA, García-Segura JM, Benito-León J, Gómez-Escalonilla C, del Ser T, Martínez V, Viaño J. 2002. Proton magnetic resonance spectroscopy in dementia with Lewy bodies. Eur Neurol. 48:158-163.
48. Nair A, Treiber JM, Shukla DK, Shih P, Müller RA. 2013. Impaired thala-mocortical connectivity in autism spectrum disorder: a study of functional and anatomical connectivity. Brain. 136:1942-1955.
49. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. 2001. Java-based graphical user interface for the MRUI quantitation package. Magma. 12:141-152.
50. O'Brien JT, Firbank MJ, Mosimann UP, Burn DJ, McKeith IG. 2005. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res. 139:79-88.
51. Onofrj M, Thomas A, Iacono D, Luciano AL, Di Iorio A. 2003. The effects of a cholinesterase inhibitor are prominent in patients with fluctuating cognition: a part 3 study of the main mechanism of cholinesterase inhibitors in dementia. Clin Neuropharmacol. 26:239-251.
52. Pasquier J, Michel BF, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL. 2002. Value of (99 m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 29:1342-1348.
53. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. 2011. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 56:907-922.
54. Peraza LR, Kaiser M, Firbank M, Graziadio S, Bonanni L, Onofrj M, Colloby SJ, Blamire A, O'Brien JT, Taylor JP. 2014. fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. Neuroimage Clin. 4:558-565.
55. Perry E, Court J, Goodchild R, Griffiths M, Jaros E, Johnson M, Lloyd S, Piggott M, Spurden D, Ballard C et al. 1998. Clinical neurochem-istry: developments in dementia research based on brain bank material. J Neural Transm. 105:915-933.
56. Perry E, Walker M, Grace J, Perry R. 1999. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 22:273-280.
57. Piggott MA, Ballard CG, Dickinson HO, McKeith IG, Perry RH, Perry EK. 2007. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. Int J Neuro-psychopharmacol. 10:231-234.
58. Pimlott SL, Piggott M, Ballard C, McKeith I, Perry R, Kometa S, Owens J, Wyper D, Perry E. 2006. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neuro-biol Dis. 21:50-56.
59. Saalmann YB, Pinsk MA, Wang L, Li X, Kastner S. 2012. The pulvinar regulates information transmission between cortical areas based on attention demands. Science. 337:753-756.
60. Schiff ND. 2008. Central thalamic contributions to arousal regulation and neurological disorders of consciousness. Ann N Y Acad Sci. 1129:105-118.
61. Sherman SM. 2007. The thalamus is more than just a relay. Curr Opin Neurobiol. 17:417-422.
62. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE et al. 2004. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 23(Suppl 1):S208-S219.
63. Steriade M. 2006. Grouping of brain rhythms in corticothalamic systems. Neuroscience. 137:1087-1106.
64. Stone JM, Dietrich C, Edden R, Mehta MA, De Simoni S, Reed LJ, Krystal JH, Nutt D, Barker GJ. 2012. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psy-chopathology. Mol Psychiatry. 17:664-665.
65. Taylor JP, Colloby SJ, McKeith IG, O'Brien JT. 2013. Covariant perfu-sion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies. Int Psy-chogeriatr. 23:1-12.
66. Thiebaut de Schotten M, Dell'Acqua F, Forkel SJ, Simmons A, Vergani F, Murphy DG, Catani M. 2011. A lateralized brain network for visuospatial attention. Nat Neurosci. 14:1245-1246.
67. Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. 2002. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry. 59:946-951.
68. Tomasi D, Wang RL, Telang F, Boronikolas V, Jayne MC, Wang GJ, Fowler JS, Volkow ND. 2009. Impairment of attentional networks after 1 night of sleep deprivation. Cereb Cortex. 19:233-240.
69. Valenzuela MJ, Sachdev P. 2001. Magnetic resonance spectroscopy in AD. Neurology. 56:592-598.
70. Van Der Werf YD, Weerts JG, Jolles J, Witter MP, Lindeboom J, Scheltens P. 1999. Neuropsychological correlates of a right unilateral lacunar thalamic infarction. J Neurol Neurosurg Psychiatry. 66:36-42.
71. Volkow N, Wang G, Hitzemann R, Fowler J, Pappas N, Lowrimore P, Burr G, Pascani K, Overall J, Wolf A. 1995. Depression of thalamic metabolism by lorazepam is associated with sleepiness. Neuropsy-chopharmacology. 12:123-132.
72. Walker MP, Ayre GA, Cummings JL, Wesnes K, McKeith IG, O'Brien JT, Ballard CG. 2000. The clinician assessment of fluctuation and the one day fluctuation assessment scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry. 177:252-256.
73. Ward LM. 2011. The thalamic dynamic core theory of conscious experience. Conscious Cogn. 20:464-486.
74. Watson R, Blamire AM, Colloby SJ, Wood JS, Barber R, He J, O'Brien JT. 2012. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology. 79:906-914.
75. Wesnes KA, McKeith I, Edgar C, Emre M, Lane R. 2005. Benefits of riv-astigmine on attention in dementia associated with Parkinson disease. Neurology. 65:1654-1656.
76. World Health Organization. 1992. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization.
77. Wurtman RJ, Blusztajn JK, Marie JC. 1985. Autocannibalism of choline-containing membrane phospholipids in the pathogenesis of Alzheimer's disease. Neurochem Int. 7:369-372.
78. Zarei M, Patenaude B, Damoiseaux J, Morgese C, Smith S, Matthews PM, Barkhof F, Rombouts SA, Sanz-Arigita E, Jenkinson M. 2010. Combining shape and connectivity analysis: an MRI study of thal-amic degeneration in Alzheimer's disease. Neuroimage. 49:1-8.